Study of Participants With Crohn's Disease and Ulcerative Colitis in Eastern Europe, Middle East, and North Africa (P08166)

Merck Sharp & Dohme (MSD)

Status: Withdrawn

Conditions: Inflammatory Bowel Disease; Ulcerative Colitis; Crohn's Disease

Treatments: Other: No intervention.

Study type: Observational

Funder types: Industry

Identifiers

NCT01293656

P08166

Details and patient eligibility

About

This study is being done to assess the clinical course and treatment options for Crohn's Disease (CD) and ulcerative colitis (UC) in the populations of Eastern Europe, Middle East, and North Africa.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Confirmed diagnosis of Crohn's disease or ulcerative colitis.

Trial design

0 participants in 1 patient group

CD and UC participants

Description:

All participants with CD or UC visiting their physician over a period of one year, newly and already diagnosed, regardless of treatment pattern.

Treatment:

Other: No intervention.